首页> 外文期刊>Beneficial Microbe >Antibacterial activity of selected medicinal plants against multiple antibiotic resistant uropathogens: a study from Kolli Hills, Tamil Nadu, India
【24h】

Antibacterial activity of selected medicinal plants against multiple antibiotic resistant uropathogens: a study from Kolli Hills, Tamil Nadu, India

机译:精选药用植物对多种抗生素抗性尿毒症的抗菌活性:来自印度泰米尔纳德邦Kolli Hills的一项研究

获取原文
获取原文并翻译 | 示例
           

摘要

The increasing incidence of antibiotic resistance among bacterial pathogens necessitates medicinal plants as an alternate therapy in restricting the resistant infectious organisms. In this primitive study, the antibiotic resistance of organisms isolated from urinary tract infected patients was evaluated using the National Committee for Clinical Laboratory Standards (NCCLS) method and Multiple Antibiotic Resistance (MAR) index values, and the MAR values was also calculated for plant extracts. The 10 common medicinal plants collected from Kolli hills, Namakkal, south India were extracted using the chloroform, methanol, acetone, ethanol and saponification procedure. The efficacy of the extracts on the uropathogens was tested by agar disc diffusion method in order to analyse the inhibitory activity of plant extract on the organisms. Azadiracta indica A. Juss., Tinospora cordifolia (Wild.) and Euphorbia hirta Linn, exhibited high inhibitory activity against most of the 11 tested organisms followed by Cassia javanica Linn, and Phyllanthus niruri Linn. The maximum zone size of 46.3 mm was exhibited by methanol extract of P. niruri Linn, against Pseudomonas aeruginosa. Asparagus racemosus Willd. and Eupatorium triplinerve Vahl had the least activity against resistant pathogens. Saponified lipids of most of the plants exhibited maximum antibacterial activity. Among the tested organisms, P. aeruginosa and Staphylococcus epidermidis were the most susceptible and Serratia marcescens, Enterobacter cloaceae, Citrobacter koseri, and Citrobacter freundii were the least inhibited by most of the extracts of medicinal plants. It is concluded that revised antibiotic policies and more importantly the development of herbal medicine as an alternative may be incorporated in urological practice.
机译:细菌病原体中抗生素耐药性的发生率不断上升,因此药用植物必须作为限制耐药菌的替代疗法。在这项原始研究中,使用美国国家临床实验室标准委员会(NCCLS)方法和多重抗生素抗性(MAR)指数值评估了从尿路感染患者中分离出的生物体的抗生素抗性,并且还计算了植物提取物的MAR值。使用氯仿,甲醇,丙酮,乙醇和皂化工艺提取了从印度南部那马卡尔邦的科利山收集的10种常见药用植物。为了分析植物提取物对生物的抑制活性,通过琼脂圆盘扩散法测试了提取物对尿路致病菌的功效。 Azadiracta indica A. Juss,Tinospora cordifolia(Wild。)和Euphorbia hirta Linn对11种受测生物中的大多数均表现出高抑制活性,其次是Cassia javanica Linn和Phyllanthus niruri Linn。 P. niruri Linn的甲醇提取物对铜绿假单胞菌的最大区带大小为46.3 mm。芦笋racemosus Willd。 Eupatorium triplinerve Vahl对耐药病原体的活性最小。大多数植物的皂化脂质表现出最大的抗菌活性。在测试的生物中,铜绿假单胞菌和表皮葡萄球菌最易感,而粘质沙雷氏菌,阴沟肠杆菌,科氏柠檬酸杆菌和弗氏柠檬酸杆菌被大多数药用植物提取物抑制最小。结论是,修订的抗生素政策以及更重要的是发展草药替代疗法可以纳入泌尿外科。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号